MedTrace Logo

Prenatal Examination of Deletion 22q11 Syndrome : Thymic Dysgenesis THYMI Study

NCT02890472 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 13

Last updated 2021-01-27

No results posted yet for this study

Summary

22q11.2 microdeletion seems the prenatally under-diagnosed . Indeed , there is a mismatch between the series on the heart rate of 22q11.2 antenatal 84% against 30% in the adult series despite a perinatal mortality of 16% suggesting opportunities for improvement in the prenatal diagnosis of fetus with a microdeletion 22q11.2 , especially without heart disease

Conditions

  • 22q11 Deletion Syndrome Di George Syndrome

Sponsors & Collaborators

  • Centre Hospitalier Universitaire de Nīmes

    lead OTHER

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-01
Primary Completion
2020-07-01
Completion
2020-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02890472 on ClinicalTrials.gov